echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Predict your immunity to Covid-19

    Predict your immunity to Covid-19

    • Last Update: 2022-08-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In the United States, most people have some degree of immune protection against Covid-19, either through vaccination, infection, or a combination of the two


    Easy access to such tests could help people determine what precautions they should take to prevent catching the virus, such as getting an extra booster shot, the researchers said


    "In the general population, many people may wonder how protected they are," said Hojun Li, a researcher at MIT's Koch Institute for Integrative Cancer Research


    a simple test

    Li joined the Koch Institute in the fall of 2019 to study blood cell development and how blood cells become cancerous


    Currently, the gold standard method for measuring immunity involves mixing a blood sample with live virus and measuring how many cells in the sample are killed by the virus


    Li had no experience with the test, so he turned to two MIT faculty with expertise in designing diagnostics based on lateral flow assays: Hadley Sikes, associate professor of chemical engineering, and health sciences and technology, electrical engineering with Sangeeta Bhatia, professor of computer science and member of the Koch Institute


    The first step in the test is to mix a human blood sample with the viral RBD protein, which is labeled with tiny gold particles that can be seen when glued to paper


    To develop the reagents needed for the test, members of Li's lab collaborated with the labs of Angela Koehler, associate professor of bioengineering, and Michael Yaffe, the David H.


    Predictive immunity

    In addition to the test cartridge containing paper test strips, the test kit also includes a finger lancet that can be used to obtain small blood samples of less than 10 microliters


    The researchers tested their device with blood samples collected in December 2020 from about 60 SARS-CoV-2 infected people and 30 uninfected people


    Previous research on SARS-CoV-2 and other viruses has shown a strong correlation between the amount of neutralizing antibodies circulating in an individual's blood and their likelihood of infection


    Li said the test could be easily adapted to different SARS-CoV-2 variants by swapping out a reagent that targets the RBD of the different variants


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.